2000
Gene expression, localization, and pharmacological characterization of endothelin receptors in diabetic rat bladder dome
Saito M, Wada Y, Ikeda K, Wang Z, Smith S, Foster H, Nishi K, Weiss R, Latifpour J. Gene expression, localization, and pharmacological characterization of endothelin receptors in diabetic rat bladder dome. European Journal Of Pharmacology 2000, 387: 253-263. PMID: 10650170, DOI: 10.1016/s0014-2999(99)00753-0.Peer-Reviewed Original ResearchConceptsRat bladder domeEndothelin receptorsBladder domeInsulin treatmentReceptor subtypesFunctional endothelin receptorsMammalian urinary tractEndothelin receptor subtypesInduction of diabetesAge-matched controlsReceptor alterationsExperimental diabetesUrinary tractPharmacological characterizationPharmacological profileMuscular layerMRNA upregulationAutoradiographic studyTranscription-polymerase chain reaction dataReceptorsExpression levelsDiabetesTissue componentsSubtypesTreatment
1992
Effect of Insulin and Dietary Myoinositol on Muscarinic Receptor Alterations in Diabetic Rat Bladder
Latifpour J, Gousse A, Yoshida M, Weiss R. Effect of Insulin and Dietary Myoinositol on Muscarinic Receptor Alterations in Diabetic Rat Bladder. Journal Of Urology 1992, 147: 760-763. PMID: 1538479, DOI: 10.1016/s0022-5347(17)37374-3.Peer-Reviewed Original ResearchConceptsDietary myoinositolBladder domeMuscarinic receptorsReceptor densityLower serum insulin levelsDiabetic rat bladderMuscarinic receptor alterationsStreptozotocin-injected ratsMuscarinic receptor densitySerum insulin levelsHigher serum glucoseGroups of ratsRadioligand receptor binding assaysEffect of insulinReceptor binding assaysHigh water intakeUrine outputDiabetic ratsReceptor alterationsInsulin levelsSerum glucoseRat bladderRatsInsulinInduced abnormalities